C
CONMED Corporation
CNMD
$59.12
-$2.81-4.54%
C
Hold
3/7/2025Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 3/7/2025 due to an increase in the valuation index, volatility index and dividend index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 3/7/2025 due to an increase in the valuation index, volatility index and dividend index.
D
Sell
2/19/2025Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 2/19/2025 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $1.57 to $1.0803, and operating cash flow declined 15.36% from $51.2M to $43.34M.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 2/19/2025 due to a decline in the growth index, volatility index and total return index. Earnings per share declined from $1.57 to $1.0803, and operating cash flow declined 15.36% from $51.2M to $43.34M.
C
Hold
2/5/2025Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 2/5/2025 due to an increase in the volatility index, total return index and growth index.
D
Sell
1/21/2025Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 1/21/2025 due to a decline in the volatility index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 1/21/2025 due to a decline in the volatility index.
C
Hold
1/6/2025Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 1/6/2025 due to an increase in the volatility index, valuation index and dividend index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 1/6/2025 due to an increase in the volatility index, valuation index and dividend index.
D
Sell
12/20/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 12/20/2024 due to a decline in the volatility index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 12/20/2024 due to a decline in the volatility index.
C
Hold
11/19/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 11/19/2024 due to an increase in the valuation index, efficiency index and solvency index. Net income increased 63.41% from $29.98M to $48.98M, debt to equity declined from 1.09 to 1.01, and total capital increased 1.41% from $1.85B to $1.87B.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 11/19/2024 due to an increase in the valuation index, efficiency index and solvency index. Net income increased 63.41% from $29.98M to $48.98M, debt to equity declined from 1.09 to 1.01, and total capital increased 1.41% from $1.85B to $1.87B.
D
Sell
10/28/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 10/28/2024 due to a decline in the total return index and volatility index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 10/28/2024 due to a decline in the total return index and volatility index.
C
Hold
10/11/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 10/11/2024 due to an increase in the valuation index, volatility index and dividend index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 10/11/2024 due to an increase in the valuation index, volatility index and dividend index.
D
Sell
9/26/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 9/26/2024 due to a decline in the volatility index, valuation index and total return index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 9/26/2024 due to a decline in the volatility index, valuation index and total return index.
C
Hold
9/6/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 9/6/2024 due to an increase in the volatility index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 9/6/2024 due to an increase in the volatility index.
D
Sell
8/21/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 8/21/2024 due to a decline in the volatility index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 8/21/2024 due to a decline in the volatility index.
C
Hold
8/2/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 8/2/2024 due to a noticeable increase in the valuation index, growth index and volatility index. Earnings per share increased from $0.63 to $0.96, operating cash flow increased 48.71% from $29.12M to $43.31M, and EBIT increased 27.73% from $30.07M to $38.41M.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 8/2/2024 due to a noticeable increase in the valuation index, growth index and volatility index. Earnings per share increased from $0.63 to $0.96, operating cash flow increased 48.71% from $29.12M to $43.31M, and EBIT increased 27.73% from $30.07M to $38.41M.
D
Sell
7/31/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 7/31/2024 due to a decline in the volatility index, valuation index and dividend index.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 7/31/2024 due to a decline in the volatility index, valuation index and dividend index.
C
Hold
7/11/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C- from D+ on 7/11/2024 due to an increase in the volatility index and valuation index.
CONMED Corporation (CNMD) was upgraded to C- from D+ on 7/11/2024 due to an increase in the volatility index and valuation index.
D
Sell
6/25/2024Downgrade
CONMED Corporation (CNMD) was downgraded to D+ from C- on 6/25/2024 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 48.36% from $56.4M to $29.12M, earnings per share declined from $1.051 to $0.63, and EBIT declined 24.87% from $40.02M to $30.07M.
CONMED Corporation (CNMD) was downgraded to D+ from C- on 6/25/2024 due to a large decline in the growth index, total return index and solvency index. Operating cash flow declined 48.36% from $56.4M to $29.12M, earnings per share declined from $1.051 to $0.63, and EBIT declined 24.87% from $40.02M to $30.07M.
C
Hold
3/27/2024Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 3/27/2024 due to a decline in the total return index.
CONMED Corporation (CNMD) was downgraded to C- from C on 3/27/2024 due to a decline in the total return index.
C
Hold
2/29/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 2/29/2024 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.5 to $1.051, net income increased 108.82% from $15.84M to $33.07M, and operating cash flow increased 22.26% from $46.13M to $56.4M.
CONMED Corporation (CNMD) was upgraded to C from C- on 2/29/2024 due to a significant increase in the growth index, valuation index and efficiency index. Earnings per share increased from $0.5 to $1.051, net income increased 108.82% from $15.84M to $33.07M, and operating cash flow increased 22.26% from $46.13M to $56.4M.
C
Hold
2/14/2024Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 2/14/2024 due to a decline in the total return index, volatility index and growth index.
CONMED Corporation (CNMD) was downgraded to C- from C on 2/14/2024 due to a decline in the total return index, volatility index and growth index.
C
Hold
1/30/2024Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 1/30/2024 due to an increase in the valuation index and dividend index.
CONMED Corporation (CNMD) was upgraded to C from C- on 1/30/2024 due to an increase in the valuation index and dividend index.
C
Hold
11/14/2023Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 11/14/2023 due to a decline in the efficiency index, valuation index and solvency index.
CONMED Corporation (CNMD) was downgraded to C- from C on 11/14/2023 due to a decline in the efficiency index, valuation index and solvency index.
C
Hold
10/27/2023Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 10/27/2023 due to a noticeable increase in the growth index and solvency index. Operating cash flow increased 72.94% from $26.67M to $46.13M, earnings per share increased from $0.43 to $0.5, and EBIT increased 12.82% from $28.81M to $32.5M.
CONMED Corporation (CNMD) was upgraded to C from C- on 10/27/2023 due to a noticeable increase in the growth index and solvency index. Operating cash flow increased 72.94% from $26.67M to $46.13M, earnings per share increased from $0.43 to $0.5, and EBIT increased 12.82% from $28.81M to $32.5M.
C
Hold
10/18/2023Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 10/18/2023 due to a large decline in the total return index, volatility index and efficiency index.
CONMED Corporation (CNMD) was downgraded to C- from C on 10/18/2023 due to a large decline in the total return index, volatility index and efficiency index.
C
Hold
7/28/2023Upgraded
CONMED Corporation (CNMD) was upgraded to C from D+ on 7/28/2023 due to a substantial increase in the efficiency index, growth index and valuation index. Operating cash flow increased 793.35% from -$3.85M to $26.67M, net income increased 654.92% from $1.82M to $13.73M, and earnings per share increased from $0.0596 to $0.43.
CONMED Corporation (CNMD) was upgraded to C from D+ on 7/28/2023 due to a substantial increase in the efficiency index, growth index and valuation index. Operating cash flow increased 793.35% from -$3.85M to $26.67M, net income increased 654.92% from $1.82M to $13.73M, and earnings per share increased from $0.0596 to $0.43.
D
Sell
7/6/2023Upgraded
CONMED Corporation (CNMD) was upgraded to D+ from D on 7/6/2023 due to an increase in the volatility index, total return index and efficiency index.
CONMED Corporation (CNMD) was upgraded to D+ from D on 7/6/2023 due to an increase in the volatility index, total return index and efficiency index.
D
Sell
7/29/2022Downgrade
CONMED Corporation (CNMD) was downgraded to D from C on 7/29/2022 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.4748 to -$5.6521, and net income declined 1,223.81% from $14.98M to -$168.29M.
CONMED Corporation (CNMD) was downgraded to D from C on 7/29/2022 due to a significant decline in the growth index, efficiency index and valuation index. Earnings per share declined from $0.4748 to -$5.6521, and net income declined 1,223.81% from $14.98M to -$168.29M.
C
Hold
7/11/2022Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 7/11/2022 due to a decline in the total return index and volatility index.
CONMED Corporation (CNMD) was downgraded to C from C+ on 7/11/2022 due to a decline in the total return index and volatility index.
C
Hold
5/6/2022Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 5/6/2022 due to a major decline in the total return index, growth index and solvency index. Operating cash flow declined 99.03% from $33.79M to $328, EBIT declined 39.7% from $37.22M to $22.44M, and earnings per share declined from $0.7445 to $0.4748.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 5/6/2022 due to a major decline in the total return index, growth index and solvency index. Operating cash flow declined 99.03% from $33.79M to $328, EBIT declined 39.7% from $37.22M to $22.44M, and earnings per share declined from $0.7445 to $0.4748.
B
Buy
4/26/2022Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 4/26/2022 due to an increase in the total return index, volatility index and solvency index.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 4/26/2022 due to an increase in the total return index, volatility index and solvency index.
C
Hold
3/15/2022Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 3/15/2022 due to a decline in the total return index.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 3/15/2022 due to a decline in the total return index.
B
Buy
2/24/2022Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 2/24/2022 due to a noticeable increase in the growth index, valuation index and total return index. Earnings per share increased from $0.47 to $0.7445, operating cash flow increased 58.15% from $21.36M to $33.79M, and EBIT increased 39.32% from $26.72M to $37.22M.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 2/24/2022 due to a noticeable increase in the growth index, valuation index and total return index. Earnings per share increased from $0.47 to $0.7445, operating cash flow increased 58.15% from $21.36M to $33.79M, and EBIT increased 39.32% from $26.72M to $37.22M.
C
Hold
2/23/2022Upgraded
CONMED Corporation (CNMD) was upgraded to C+ from C on 2/23/2022 due to a large increase in the total return index, growth index and efficiency index.
CONMED Corporation (CNMD) was upgraded to C+ from C on 2/23/2022 due to a large increase in the total return index, growth index and efficiency index.
C
Hold
1/25/2022Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 1/25/2022 due to a substantial decline in the total return index.
CONMED Corporation (CNMD) was downgraded to C from C+ on 1/25/2022 due to a substantial decline in the total return index.
C
Hold
1/7/2022Upgraded
CONMED Corporation (CNMD) was upgraded to C+ from C on 1/7/2022 due to a noticeable increase in the total return index and volatility index.
CONMED Corporation (CNMD) was upgraded to C+ from C on 1/7/2022 due to a noticeable increase in the total return index and volatility index.
C
Hold
12/21/2021Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 12/21/2021 due to a decline in the total return index.
CONMED Corporation (CNMD) was downgraded to C from C+ on 12/21/2021 due to a decline in the total return index.
C
Hold
11/12/2021Upgraded
CONMED Corporation (CNMD) was upgraded to C+ from C on 11/12/2021 due to a large increase in the total return index and efficiency index. Net income increased 12.48% from $13.29M to $14.95M.
CONMED Corporation (CNMD) was upgraded to C+ from C on 11/12/2021 due to a large increase in the total return index and efficiency index. Net income increased 12.48% from $13.29M to $14.95M.
C
Hold
8/16/2021Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 8/16/2021 due to a decline in the total return index, growth index and volatility index.
CONMED Corporation (CNMD) was downgraded to C from C+ on 8/16/2021 due to a decline in the total return index, growth index and volatility index.
C
Hold
7/30/2021Upgraded
CONMED Corporation (CNMD) was upgraded to C+ from C on 7/30/2021 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 53.41% from $22.34M to $34.28M, net income increased 34.79% from $9.86M to $13.29M, and earnings per share increased from $0.31 to $0.41.
CONMED Corporation (CNMD) was upgraded to C+ from C on 7/30/2021 due to a significant increase in the growth index, valuation index and efficiency index. Operating cash flow increased 53.41% from $22.34M to $34.28M, net income increased 34.79% from $9.86M to $13.29M, and earnings per share increased from $0.31 to $0.41.
C
Hold
7/20/2021Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 7/20/2021 due to an increase in the total return index and dividend index.
CONMED Corporation (CNMD) was upgraded to C from C- on 7/20/2021 due to an increase in the total return index and dividend index.
C
Hold
7/1/2021Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 7/1/2021 due to a noticeable decline in the total return index.
CONMED Corporation (CNMD) was downgraded to C- from C on 7/1/2021 due to a noticeable decline in the total return index.
C
Hold
5/19/2021Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 5/19/2021 due to a major increase in the total return index and volatility index.
CONMED Corporation (CNMD) was upgraded to C from C- on 5/19/2021 due to a major increase in the total return index and volatility index.
C
Hold
5/4/2021Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 5/4/2021 due to a large decline in the total return index, growth index and dividend index. Earnings per share declined from $0.8009 to $0.31, EBIT declined 23.58% from $26.83M to $20.5M, and total revenue declined 7.97% from $252.83M to $232.68M.
CONMED Corporation (CNMD) was downgraded to C- from C on 5/4/2021 due to a large decline in the total return index, growth index and dividend index. Earnings per share declined from $0.8009 to $0.31, EBIT declined 23.58% from $26.83M to $20.5M, and total revenue declined 7.97% from $252.83M to $232.68M.
C
Hold
4/16/2021Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 4/16/2021 due to a significant increase in the total return index, growth index and efficiency index. Net income increased 252.41% from $6.85M to $24.14M, earnings per share increased from $0.23 to $0.8009, and total revenue increased 6.3% from $237.84M to $252.83M.
CONMED Corporation (CNMD) was upgraded to C from C- on 4/16/2021 due to a significant increase in the total return index, growth index and efficiency index. Net income increased 252.41% from $6.85M to $24.14M, earnings per share increased from $0.23 to $0.8009, and total revenue increased 6.3% from $237.84M to $252.83M.
C
Hold
7/31/2020Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 7/31/2020 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.2 to -$0.96, net income declined 562.29% from $5.93M to -$27.4M, and EBIT declined 127.89% from $16.43M to -$4.58M.
CONMED Corporation (CNMD) was downgraded to C- from C on 7/31/2020 due to a significant decline in the growth index, valuation index and efficiency index. Earnings per share declined from $0.2 to -$0.96, net income declined 562.29% from $5.93M to -$27.4M, and EBIT declined 127.89% from $16.43M to -$4.58M.
C
Hold
5/6/2020Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 5/6/2020 due to a substantial decline in the volatility index, total return index and growth index. Operating cash flow declined 90.9% from $40.88M to $3.72M, earnings per share declined from $0.4856 to $0.2, and EBIT declined 46.76% from $30.86M to $16.43M.
CONMED Corporation (CNMD) was downgraded to C from C+ on 5/6/2020 due to a substantial decline in the volatility index, total return index and growth index. Operating cash flow declined 90.9% from $40.88M to $3.72M, earnings per share declined from $0.4856 to $0.2, and EBIT declined 46.76% from $30.86M to $16.43M.
C
Hold
2/26/2020Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/26/2020 due to a noticeable decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.27 to 1.14.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/26/2020 due to a noticeable decline in the total return index, volatility index and solvency index. The quick ratio declined from 1.27 to 1.14.
B
Buy
2/21/2020Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 2/21/2020 due to an increase in the volatility index and valuation index.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 2/21/2020 due to an increase in the volatility index and valuation index.
C
Hold
2/6/2020Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/6/2020 due to a decline in the total return index, valuation index and efficiency index. Total capital declined 0.57% from $1.52B to $1.51B.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/6/2020 due to a decline in the total return index, valuation index and efficiency index. Total capital declined 0.57% from $1.52B to $1.51B.
B
Buy
8/2/2019Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 8/2/2019 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 650.43% from -$3.92M to $21.58M, earnings per share increased from $0.0362 to $0.19, and EBIT increased 10.82% from $19.22M to $21.3M.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 8/2/2019 due to a significant increase in the growth index, volatility index and solvency index. Operating cash flow increased 650.43% from -$3.92M to $21.58M, earnings per share increased from $0.0362 to $0.19, and EBIT increased 10.82% from $19.22M to $21.3M.
C
Hold
5/1/2019Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 5/1/2019 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 115.87% from $24.7M to -$3.92M, net income declined 93.48% from $15.65M to $1.02M, and earnings per share declined from $0.5403 to $0.0362.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 5/1/2019 due to a significant decline in the growth index, solvency index and efficiency index. Operating cash flow declined 115.87% from $24.7M to -$3.92M, net income declined 93.48% from $15.65M to $1.02M, and earnings per share declined from $0.5403 to $0.0362.
B
Buy
3/29/2019Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 3/29/2019 due to a large increase in the total return index, volatility index and solvency index.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 3/29/2019 due to a large increase in the total return index, volatility index and solvency index.
C
Hold
2/27/2019Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/27/2019 due to a significant decline in the valuation index, volatility index and efficiency index.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 2/27/2019 due to a significant decline in the valuation index, volatility index and efficiency index.
B
Buy
12/20/2018Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 12/20/2018 due to a decline in the total return index, growth index and efficiency index. Operating cash flow declined 78.9% from $20.63M to $4.35M, earnings per share declined from $0.3 to $0.2, and net income declined 33.19% from $8.72M to $5.83M.
CONMED Corporation (CNMD) was downgraded to B- from B on 12/20/2018 due to a decline in the total return index, growth index and efficiency index. Operating cash flow declined 78.9% from $20.63M to $4.35M, earnings per share declined from $0.3 to $0.2, and net income declined 33.19% from $8.72M to $5.83M.
B
Buy
8/14/2018Upgraded
CONMED Corporation (CNMD) was upgraded to B from B- on 8/14/2018 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 5.32% from $202.06M to $212.82M.
CONMED Corporation (CNMD) was upgraded to B from B- on 8/14/2018 due to an increase in the growth index, volatility index and efficiency index. Total revenue increased 5.32% from $202.06M to $212.82M.
B
Buy
4/30/2018Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 4/30/2018 due to a noticeable decline in the growth index and dividend index. Earnings per share declined from $1.6531 to $0.37, EBIT declined 31.04% from $25.06M to $17.28M, and total revenue declined 9.21% from $222.56M to $202.06M.
CONMED Corporation (CNMD) was downgraded to B- from B on 4/30/2018 due to a noticeable decline in the growth index and dividend index. Earnings per share declined from $1.6531 to $0.37, EBIT declined 31.04% from $25.06M to $17.28M, and total revenue declined 9.21% from $222.56M to $202.06M.
B
Buy
3/2/2018Upgraded
CONMED Corporation (CNMD) was upgraded to B from C on 3/2/2018 due to a significant increase in the growth index, valuation index and total return index. Earnings per share increased from $0.2577 to $1.6531, EBIT increased 64.51% from $15.23M to $25.06M, and operating cash flow increased 54.99% from $13.43M to $20.81M.
CONMED Corporation (CNMD) was upgraded to B from C on 3/2/2018 due to a significant increase in the growth index, valuation index and total return index. Earnings per share increased from $0.2577 to $1.6531, EBIT increased 64.51% from $15.23M to $25.06M, and operating cash flow increased 54.99% from $13.43M to $20.81M.
C
Hold
4/10/2017Upgraded
CONMED Corporation (CNMD) was upgraded to C from C- on 4/10/2017 due to an increase in the total return index and volatility index.
CONMED Corporation (CNMD) was upgraded to C from C- on 4/10/2017 due to an increase in the total return index and volatility index.
C
Hold
3/24/2017Downgrade
CONMED Corporation (CNMD) was downgraded to C- from C on 3/24/2017 due to a substantial decline in the valuation index, volatility index and growth index. Operating cash flow declined 45.15% from $24.76M to $13.58M, and earnings per share declined from $0.26 to $0.24.
CONMED Corporation (CNMD) was downgraded to C- from C on 3/24/2017 due to a substantial decline in the valuation index, volatility index and growth index. Operating cash flow declined 45.15% from $24.76M to $13.58M, and earnings per share declined from $0.26 to $0.24.
C
Hold
2/25/2016Downgrade
CONMED Corporation (CNMD) was downgraded to C from C+ on 2/25/2016 due to a substantial decline in the growth index, total return index and valuation index. Operating cash flow declined 31.59% from $13.67M to $9.35M, and earnings per share declined from $0.32 to $0.28.
CONMED Corporation (CNMD) was downgraded to C from C+ on 2/25/2016 due to a substantial decline in the growth index, total return index and valuation index. Operating cash flow declined 31.59% from $13.67M to $9.35M, and earnings per share declined from $0.32 to $0.28.
C
Hold
1/19/2016Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 1/19/2016 due to a noticeable decline in the total return index and volatility index.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 1/19/2016 due to a noticeable decline in the total return index and volatility index.
B
Buy
10/23/2015Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 10/23/2015 due to a large increase in the growth index, valuation index and solvency index. Operating cash flow increased 33.37% from $10.25M to $13.67M, earnings per share increased from $0.27 to $0.32, and EBIT increased 7.71% from $16.23M to $17.49M.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 10/23/2015 due to a large increase in the growth index, valuation index and solvency index. Operating cash flow increased 33.37% from $10.25M to $13.67M, earnings per share increased from $0.27 to $0.32, and EBIT increased 7.71% from $16.23M to $17.49M.
C
Hold
10/8/2015Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 10/8/2015 due to a significant decline in the volatility index, total return index and efficiency index.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 10/8/2015 due to a significant decline in the volatility index, total return index and efficiency index.
B
Buy
6/23/2015Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 6/23/2015 due to a decline in the valuation index and volatility index.
CONMED Corporation (CNMD) was downgraded to B- from B on 6/23/2015 due to a decline in the valuation index and volatility index.
B
Buy
6/8/2015Upgraded
CONMED Corporation (CNMD) was upgraded to B from B- on 6/8/2015 due to a major increase in the total return index, solvency index and volatility index.
CONMED Corporation (CNMD) was upgraded to B from B- on 6/8/2015 due to a major increase in the total return index, solvency index and volatility index.
B
Buy
4/24/2015Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 4/24/2015 due to a major decline in the growth index, valuation index and efficiency index. Net income declined 44.33% from $11.34M to $6.31M, earnings per share declined from $0.4099 to $0.2289, and operating cash flow declined 42.26% from $25.65M to $14.81M.
CONMED Corporation (CNMD) was downgraded to B- from B on 4/24/2015 due to a major decline in the growth index, valuation index and efficiency index. Net income declined 44.33% from $11.34M to $6.31M, earnings per share declined from $0.4099 to $0.2289, and operating cash flow declined 42.26% from $25.65M to $14.81M.
B
Buy
2/25/2015Upgraded
CONMED Corporation (CNMD) was upgraded to B from B- on 2/25/2015 due to a substantial increase in the growth index, volatility index and efficiency index. Earnings per share increased from $0.07 to $0.4099, net income increased 475% from $1.97M to $11.34M, and operating cash flow increased 75.47% from $14.62M to $25.65M.
CONMED Corporation (CNMD) was upgraded to B from B- on 2/25/2015 due to a substantial increase in the growth index, volatility index and efficiency index. Earnings per share increased from $0.07 to $0.4099, net income increased 475% from $1.97M to $11.34M, and operating cash flow increased 75.47% from $14.62M to $25.65M.
B
Buy
2/2/2015Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 2/2/2015 due to a decline in the valuation index and dividend index.
CONMED Corporation (CNMD) was downgraded to B- from B on 2/2/2015 due to a decline in the valuation index and dividend index.
B
Buy
1/16/2015Upgraded
CONMED Corporation (CNMD) was upgraded to B from B- on 1/16/2015 due to a large increase in the volatility index and total return index.
CONMED Corporation (CNMD) was upgraded to B from B- on 1/16/2015 due to a large increase in the volatility index and total return index.
B
Buy
12/19/2014Upgraded
CONMED Corporation (CNMD) was upgraded to B- from C+ on 12/19/2014 due to a noticeable increase in the volatility index and total return index.
CONMED Corporation (CNMD) was upgraded to B- from C+ on 12/19/2014 due to a noticeable increase in the volatility index and total return index.
C
Hold
10/24/2014Downgrade
CONMED Corporation (CNMD) was downgraded to C+ from B- on 10/24/2014 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.37 to $0.07, EBIT declined 16.99% from $19.2M to $15.94M, and total revenue declined 7.04% from $186.78M to $173.63M.
CONMED Corporation (CNMD) was downgraded to C+ from B- on 10/24/2014 due to a substantial decline in the growth index, valuation index and volatility index. Earnings per share declined from $0.37 to $0.07, EBIT declined 16.99% from $19.2M to $15.94M, and total revenue declined 7.04% from $186.78M to $173.63M.
B
Buy
9/19/2014Downgrade
CONMED Corporation (CNMD) was downgraded to B- from B on 9/19/2014 due to a significant decline in the volatility index and total return index.
CONMED Corporation (CNMD) was downgraded to B- from B on 9/19/2014 due to a significant decline in the volatility index and total return index.
NYSE
03/12/2025 4:00PM Eastern
Quotes delayed
